Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment

Major depressive disorder (MDD) is a common and disabling syndrome with multiple etiologies that is defined by clinically elicited signs and symptoms. In hopes of developing a list of candidate biological measures that reflect and relate closely to the severity of depressive symptoms, so-called “sta...

Full description

Bibliographic Details

Published in:	Frontiers in Neuroscience
Main Authors:	Sudeepa Bhattacharyya, Boadie W. Dunlop, Siamak Mahmoudiandehkordi, Ahmed T. Ahmed, Gregory Louie, Mark A. Frye, Richard M. Weinshilboum, Ranga R. Krishnan, A. John Rush, Helen S. Mayberg, W. Edward Craighead, Rima Kaddurah-Daouk
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-09-01
Subjects:	major depression cognitive behavioral therapy metabolomics acylcarnitines branched-chain amino acids lipids
Online Access:	https://www.frontiersin.org/article/10.3389/fnins.2019.00926/full